196 related articles for article (PubMed ID: 15577674)
1. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.
Inagaki H; Nakamura T; Li C; Sugiyama T; Asaka M; Kodaira J; Iwano M; Chiba T; Okazaki K; Kato A; Ueda R; Eimoto T; Okamoto S; Sasaki N; Uemura N; Akamatsu T; Miyabayashi H; Kawamura Y; Goto H; Niwa Y; Yokoi T; Seto M; Nakamura S
Am J Surg Pathol; 2004 Dec; 28(12):1560-7. PubMed ID: 15577674
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract][Full Text] [Related]
4. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
Nakamura T; Nakamura S; Yokoi T; Suzuki H; Ohashi K; Seto M
Jpn J Cancer Res; 2002 Jun; 93(6):677-84. PubMed ID: 12079516
[TBL] [Abstract][Full Text] [Related]
6. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
7. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
[TBL] [Abstract][Full Text] [Related]
8. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin VH gene analysis in gastric MALT lymphomas.
Sakuma H; Nakamura T; Uemura N; Chiba T; Sugiyama T; Asaka M; Akamatsu T; Ueda R; Eimoto T; Goto H; Nakamura S; Inagaki H
Mod Pathol; 2007 Apr; 20(4):460-6. PubMed ID: 17334352
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
11. API2-MALT1 fusion gene in colorectal lymphoma.
Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs.
Iwano M; Okazaki K; Uchida K; Nakase H; Ohana M; Matsushima Y; Inagaki H; Chiba T
J Gastroenterol; 2004 Aug; 39(8):739-46. PubMed ID: 15338367
[TBL] [Abstract][Full Text] [Related]
14. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
15. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.
Yamamoto H; Nakamura T; Matsuo K; Tajika M; Kawai H; Ohmiya N; Niwa Y; Goto H; Nakamura S
Cancer Sci; 2008 Sep; 99(9):1769-73. PubMed ID: 18616679
[TBL] [Abstract][Full Text] [Related]
16. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
17. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.
Liu H; Ye H; Dogan A; Ranaldi R; Hamoudi RA; Bearzi I; Isaacson PG; Du MQ
Blood; 2001 Aug; 98(4):1182-7. PubMed ID: 11493468
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases.
Li C; Inagaki H; Kuo TT; Hu S; Okabe M; Eimoto T
Am J Surg Pathol; 2003 Aug; 27(8):1061-9. PubMed ID: 12883238
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation.
Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Banham AH; Ventura R; Matsumoto T; Iida M; Ohji Y; Yao T; Tsuneyoshi M; Du MQ
Gut; 2007 Oct; 56(10):1358-63. PubMed ID: 17525089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
